Skip to main content
JUBILANT PHARMOVA LIMITED logo

JUBILANT PHARMOVA LIMITED — Investor Relations & Filings

Ticker · JUBLPHARMA ISIN · INE700A01033 LEI · 335800C6LDKWF4HQH833 BSE.NS Manufacturing
Open in API
Filings indexed 1,045 across all filing types
Latest filing 2025-08-06 Report Publication Anno…
Country IN India
Listing BSE.NS JUBLPHARMA

About JUBILANT PHARMOVA LIMITED

https://www.jubilantpharmova.com/

Jubilant Pharmova Limited is an integrated global pharmaceutical company operating through three primary segments: Pharmaceuticals, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The Pharmaceuticals segment specializes in radiopharmaceuticals for nuclear medicine, allergy immunotherapy, and the development and manufacturing of generic formulations. It also provides Contract Development and Manufacturing Organization (CDMO) services for sterile injectables and non-sterile products. The CRDS division offers comprehensive drug discovery and development solutions to biopharmaceutical companies worldwide. Furthermore, the Proprietary Novel Drugs segment focuses on creating innovative therapies for oncology and autoimmune diseases. The company leverages its advanced manufacturing infrastructure and research capabilities to serve global markets with a focus on complex chemistry and specialized healthcare solutions.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of newspaper advertisements about the Notice of the 47th Annual General Meeting (AGM), e-voting information, record date, and final dividend. It mentions the dissemination of the Notice of the 47th AGM and the Annual Report for the financial year 2024-25 to members via email. The document itself is short (1981 characters) and primarily serves as an announcement of the publication and dissemination of the AGM notice and related information, rather than containing the full AGM materials or the Annual Report itself. According to the 'Menu vs Meal' rule, such a document is an announcement about the report and meeting materials, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2025-08-06 English
General Updates
Report Publication Announcement Classification · 95% confidence The document is a letter dated August 5, 2025, addressed to shareholders informing them about the dispatch of letters containing links to the Annual Report for FY 2024-25 and the Notice of the 47th Annual General Meeting (AGM). It explicitly states that the Annual Report and Notice are accessible via web links and that the letter is sent because the shareholders' email addresses are not registered. The document does not contain the Annual Report itself or substantive financial data but is an announcement regarding the availability and dispatch of the Annual Report and AGM notice. The document length is 4499 characters, which is relatively short and consistent with an announcement rather than the full report. Therefore, according to the MENU VS MEAL RULE, this document is a Report Publication Announcement (RPA) rather than the Annual Report (10-K).
2025-08-05 English
Shareholders meeting
Regulatory Filings
2025-08-05 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a detailed communication from Jubilant Pharmova Limited to shareholders regarding the deduction of tax at source (TDS) on the final dividend for the financial year 2024-25, subject to approval at the upcoming Annual General Meeting. It includes tax withholding rates, required declarations, and procedural instructions for shareholders. The content focuses on dividend tax withholding and shareholder instructions rather than announcing dividend amounts or payment dates directly. It is not a dividend amount notice (DIV) because it does not primarily announce dividend payment details but rather tax deduction procedures. It is not a regulatory filing or report publication announcement since it contains substantive procedural information and detailed tax withholding rules. The document is a regulatory disclosure under SEBI regulations about tax deduction on dividends, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure and shareholder communication about tax withholding on dividends, not a direct dividend notice or financial report.
2025-08-04 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a notification about the scheduling of the 47th Annual General Meeting (AGM) of Jubilant Pharmova Limited, including details about the date, mode (video conferencing), and the distribution of the Annual Report for the financial year 2024-25. It mentions that the Annual Report will be sent electronically or via a weblink to shareholders. The document also encloses newspaper advertisements related to the AGM and complies with SEBI regulations. The document does not contain the Annual Report itself, nor does it provide financial data or detailed report content. It is an announcement related to the AGM and the upcoming report distribution, not the report itself. The document length is short (2264 characters), consistent with an announcement rather than a full report. Therefore, this fits the category of AGM Information (AGM-R), as it pertains to materials and information shared about the Annual General Meeting.
2025-08-02 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the submission of newspaper advertisements related to the notice of transfer of equity shares/unclaimed dividend to the Investor Education and Protection Fund Authority. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial statements, detailed financial data, or report content. The document is short (1572 characters) and serves as an announcement or submission notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.